Scholarlink

<p>To investigate the association of estimated glucose disposal rate (eGDR) with CVD, including stroke and heart disease, in metabolically healthy adults. All data were drawn from the China Health and Retirement Longitudinal Study, including participants aged ≥ 45 years who were free of metabolic syndrome (MetS) at baseline. Participants were enrolled in 2015 and followed up in 2018 and 2020. The association between eGDR and CVD was evaluated using multivariable Cox regression models and restricted cubic spline (RCS). Among the 4999 participants, the median age was 61 (IQR: 55–68) years, and 2838 (56.77%) were female. During the 5-year follow-up, 885 (17.70%) individuals experienced incident CVD events, comprising 322 (6.44%) cases of stroke and 653 (13.06%) of heart disease. After adjustment for other covariates, higher eGDR levels were independently associated with lower risks of CVD (HR = 0.47, 95% CI 0.37–0.61), stroke (HR = 0.39, 95% CI 0.25–0.61), and heart disease (HR = 0.51, 95% CI 0.38–0.68). RCS analysis indicated a significant linear association of eGDR with CVD and its subtypes (all <i>P</i> for nonlinearity &gt; 0.05). Higher levels of eGDR were significantly associated with a decreased risk of CVD and its subtypes in metabolically healthy individuals.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Estimated glucose disposal rate and cardiovascular risk in metabolically healthy adults: a nationwide prospective cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月6日

查看全文
  • Wenbo Li,
  • Fang Yuan,
  • Cong Gao,
  • Wenting Li,
  • Qirui Guo,
  • Xiaoling Liao

摘要

To investigate the association of estimated glucose disposal rate (eGDR) with CVD, including stroke and heart disease, in metabolically healthy adults. All data were drawn from the China Health and Retirement Longitudinal Study, including participants aged ≥ 45 years who were free of metabolic syndrome (MetS) at baseline. Participants were enrolled in 2015 and followed up in 2018 and 2020. The association between eGDR and CVD was evaluated using multivariable Cox regression models and restricted cubic spline (RCS). Among the 4999 participants, the median age was 61 (IQR: 55–68) years, and 2838 (56.77%) were female. During the 5-year follow-up, 885 (17.70%) individuals experienced incident CVD events, comprising 322 (6.44%) cases of stroke and 653 (13.06%) of heart disease. After adjustment for other covariates, higher eGDR levels were independently associated with lower risks of CVD (HR = 0.47, 95% CI 0.37–0.61), stroke (HR = 0.39, 95% CI 0.25–0.61), and heart disease (HR = 0.51, 95% CI 0.38–0.68). RCS analysis indicated a significant linear association of eGDR with CVD and its subtypes (all P for nonlinearity > 0.05). Higher levels of eGDR were significantly associated with a decreased risk of CVD and its subtypes in metabolically healthy individuals.